As clinical research becomes increasingly digital, the legal and compliance landscape is shifting. Hal Porter, Director of Consulting Services, Clearwater, speaks with Dianne Bourque, Partner, Holland & Knight LLP, about the legal, regulatory, and ethical considerations when clinical trial data is compromised. They discuss issues related to regulatory frameworks and legal obligations, risk exposure and liability, impacts of a breach that go beyond privacy, cross border data and transfer risks, and mitigating the risk and fallout of data breaches in clinical trials. Sponsored by Clearwater.

Watch this episode: https://youtu.be/XwtZXXGmLx4

Learn more about Clearwater: https://clearwatersecurity.com/

Essential Legal Updates, Now in Audio

AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Stay At the Forefront of Health Legal Education

Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Passed by Congress with razor thin margins, the One Big Beautiful Bill Act (OBBBA) marks the largest Medicaid cut in U.S. history, slashing more than $900 billion over the next ten years, with the CBO estimating more than ten million people losing health insurance by 2034. The implications for providers, legal counsel, and other stakeholders are enormous. Harsh P. Parikh, Partner, Nixon Peabody LLP, Lloyd A. Bookman, Founding Partner, Hooper Lundy & Bookman PC, and Anne Winter, Senior Managing Director, FTI Consulting, discuss the transformative impact that the OBBBA will have on Medicaid. They cover work requirements, beneficiary eligibility and coverage requirements, funding and payment limitations, fraud and abuse provisions, the Rural Health Transformation Program, and what to expect next.

Watch this episode: https://www.youtube.com/watch?v=JDYg4KZwL0M

Essential Legal Updates, Now in Audio

AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Stay At the Forefront of Health Legal Education

Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Rob Gerberry, Senior Vice President and Chief Legal Officer, Summa Health, speaks with Michael Peregrine, Partner, McDermott Will & Schulte, about a little-known element of fiduciary responsibility that could potentially have an outsized impact on director exposure: the so-called “duty of candor.” They discuss what the duty of candor is, who owes this particular fiduciary duty, how the duty of candor kicks in during a typical corporate scenario, and how a recent decision from the Delaware Chancery Court has highlighted this issue.

Watch this episode: https://www.youtube.com/watch?v=4UejhDhNTh8

Essential Legal Updates, Now in Audio

AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Stay At the Forefront of Health Legal Education

Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.